Objective: The aim of the study was to measure pulmonary mechanics in infants with respiratory distress syndrome before extubation and to correlate pulmonary function values with successful extubation ...

The innovation—a handheld dry powder inhaler for newborns in respiratory distress—recently cleared a proof-of-concept milestone, with results published in a peer-reviewed journal. Now, inventors ...

Infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves ...

HealthDay News — The FDA has approved Surfaxin (lucinactant) to prevent respiratory distress syndrome (RDS) in premature infants. Premature infants born before 37 weeks’ gestation often cannot produce ...

A clinical trial conducted in a neonatal intensive care unit has identified a new treatment protocol to improve lung growth and function among preterm infants. Adding two weeks of continuous positive ...

Infants born preterm remain vulnerable to numerous health complications, such as respiratory distress syndrome, chronic lung disease, and pulmonary dysfunction. Moreover, extremely low gestational age ...

The most likely diagnosis for this infant is bronchiolitis. This illness is the most common reason for hospitalization of an infant or preschool-age child in the United States. [1] Bronchiolitis is ...